The In Vitro Diagnostics (IVD) Contract Manufacturing Market is being driven by Increasing demand for one-stop-shop IVD contract manufacturing
The In Vitro Diagnostics (IVD) Contract Manufacturing Market is expected to grow at a CAGR of 13.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 12966.6 million. In the realm of In Vitro Diagnostics (IVD) manufacturing, leasing equipment has emerged as a strategic business solution for end-users, particularly those with budgetary constraints. Leasing not only increases operational flexibility but also offers tax benefits, enhancing the financial performance of IVD manufacturers. The swift and uncomplicated credit approval and documentation processes associated with leasing make it an attractive option for businesses of all sizes. Shimadzu, for instance, prioritizes leasing IVD equipment to numerous end-users, including healthcare facilities in the US and abroad. Transactions for the company span from USD6,000 to USD250,000, underscoring the significant growth opportunities that leasing presents.
Get more information on In Vitro Diagnostics (IVD) Contract Manufacturing Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
225 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 13.1% |
Market growth 2025-2029 |
USD 12966.6 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
11.3 |
Key countries |
US, China, Japan, Germany, UK, South Korea, Canada, France, Italy, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The In Vitro Diagnostics (IVD) Contract Manufacturing Market involves third-party manufacturers producing diagnostic testing materials, such as assay kits and diagnostic instruments, for disease detection and monitoring. These operations offer expertise, specialized manufacturing capabilities, and economies of scale, reducing production costs for clients. The prevalence of diseases, aging population, and regulatory requirements drive market growth. Molecular diagnostics, point-of-care testing, and rapid diagnostic tests are key trends. Strategic collaborations, personalized medicine, and AI are shaping the industry. Global healthcare spending, early disease detection, patient care, and regulatory compliance are significant factors. Infectious diseases and regulatory requirements pose challenges.
The In Vitro Diagnostics (IVD) Contract Manufacturing Market is a significant segment of the global healthcare equipment industry. This market involves diagnostic testing materials manufactured by third-party specialists for IVD companies. Technavio, a leading technology research and consulting firm, categorizes this market within the larger healthcare equipment sector, which encompasses R&D of capital equipment, instruments, implants, accessories, and consumables for disease diagnosis, monitoring, and treatment. The global healthcare equipment market size is determined by the combined revenue generated by manufacturers of diagnostic equipment and devices. Contract manufacturers bring expertise, optimized operations, and production cost advantages to IVD companies, enabling them to focus on core competencies. These manufacturers offer advanced, differentiated, and clinically validated assay kits, utilizing state-of-the-art facilities.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted